NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email South African business confidence fell in the second quarter of 2025, pressured by trade uncertainties due to U.S. President Donald Trump’s “Liberation Day” tariffs and local logistical constraints, a survey showed on Wednesday.Read More